{
  "trial_id": "NCT02985268",
  "overall_assessment": "likely_ineligible",
  "inclusion": [
    {
      "criterion": "Symptomatic heart failure as defined by New York Heart Association (NYHA) class II, III or ambulatory IV;",
      "label": "met"
    },
    {
      "criterion": "Treatment and compliance with optimal medical therapy for heart failure for at least 30 days;",
      "label": "met"
    },
    {
      "criterion": "Left ventricular ejection fraction \u2264 35%, as assessed by any one of the following methods: echocardiography, contrast left ventriculography, gated blood pool scan or cardiac magnetic resonance imaging (MRI);",
      "label": "met"
    }
  ],
  "exclusion": [
    {
      "criterion": "Life expectancy less than 12 months due to noncardiac conditions;",
      "label": "triggers"
    },
    {
      "criterion": "ACC/AHA Stage D Heart Failure;",
      "label": "triggers"
    }
  ],
  "notes": "Patient has severe mitral valve prolapse with regurgitation and is symptomatic. However, they have a history of gestational diabetes mellitus and hypertension with pregnancy, which may impact their life expectancy.",
  "_meta": {
    "topic_id": "12",
    "trial_id": "NCT02985268",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}